Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event simulation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event simulation
Authors
Keywords
-
Journal
CYTOTHERAPY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-03-02
DOI
10.1016/j.jcyt.2020.08.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chimeric antigen receptor–T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods
- (2019) Richard P. Harrison et al. CYTOTHERAPY
- Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics
- (2019) Sandhya R. Panch et al. MOLECULAR THERAPY
- Automation in cell and gene therapy manufacturing: from past to future
- (2019) P. Moutsatsou et al. BIOTECHNOLOGY LETTERS
- Fresh Versus Cryopreserved/Thawed Bispecific Anti-CD19/CD20 CAR-T Cells for Relapsed, Refractory Non-Hodgkin Lymphoma
- (2019) Nirav N. Shah et al. BLOOD
- Autologous cryopreserved leukapheresis cellular material for chimeric antigen receptor–T cell manufacture
- (2019) Seshu Tyagarajan et al. CYTOTHERAPY
- The impact of increased decentralised generation on the reliability of an existing electricity network
- (2018) Anton Johannes Veldhuis et al. APPLIED ENERGY
- Building a CAR Garage: Preparing for the Delivery of Commercial CAR T Cell Products at Memorial Sloan Kettering Cancer Center
- (2018) Karlo Perica et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Centralised versus decentralised manufacturing and the delivery of healthcare products: A United Kingdom exemplar
- (2018) Richard P. Harrison et al. CYTOTHERAPY
- Cell therapy-processing economics: small-scale microfactories as a stepping stone toward large-scale macrofactories
- (2018) Richard P Harrison et al. Regenerative Medicine
- The Increasingly Human and Profitable Monoclonal Antibody Market
- (2018) António L. Grilo et al. TRENDS IN BIOTECHNOLOGY
- Quality Control and Nonclinical Research on CAR-T Cell Products: General Principles and Key Issues
- (2018) Yonghong Li et al. Engineering
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks
- (2017) Michael Morrison et al. Regenerative Medicine
- Global Manufacturing of CAR T Cell Therapy
- (2017) Bruce L. Levine et al. Molecular Therapy-Methods & Clinical Development
- CAR T-cell therapies: formulation–product–proposition framework for commercialisation
- (2016) Nafees N. Malik et al. DRUG DISCOVERY TODAY
- Distributed manufacturing: scope, challenges and opportunities
- (2016) Jagjit Singh Srai et al. INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH
- World Health Organization International Standard To Harmonize Assays for Detection of Mycoplasma DNA
- (2015) C. Micha Nübling et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Towards a commercial process for the manufacture of genetically modified T cells for therapy
- (2015) A D Kaiser et al. CANCER GENE THERAPY
- Validation of shortened 2-day sterility testing of mesenchymal stem cell-based therapeutic preparation on an automated culture system
- (2015) Daniel Lysák et al. CELL AND TISSUE BANKING
- Construction of stable packaging cell lines for clinical lentiviral vector production
- (2015) Khaled S. Sanber et al. Scientific Reports
- Wrong blood in tube - potential for serious outcomes: can it be prevented?
- (2014) Paula H. B. Bolton-Maggs et al. BRITISH JOURNAL OF HAEMATOLOGY
- Manufacturing models permitting roll out/scale out of clinically led autologous cell therapies: regulatory and scientific challenges for comparability
- (2014) Paul Hourd et al. CYTOTHERAPY
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Rethinking clinical delivery of adult stem cell therapies
- (2014) Nuala Trainor et al. NATURE BIOTECHNOLOGY
- Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs
- (2013) Mohamed Abou-El-Enein et al. CYTOTHERAPY
- An analysis of supply chain strategies in the regenerative medicine industry—Implications for future development
- (2013) Chih Wei Teng et al. INTERNATIONAL JOURNAL OF PRODUCTION ECONOMICS
- Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials
- (2013) Bipulendu Jena et al. PLoS One
- Concise Review: Guidance in Developing Commercializable Autologous/Patient-Specific Cell Therapy Manufacturing
- (2013) Shannon Eaker et al. Stem Cells Translational Medicine
- Large-Scale Production Means for the Manufacturing of Lentiviral Vectors
- (2010) M. Schweizer et al. CURRENT GENE THERAPY
- Discrete event simulation for performance modelling in health care: a review of the literature
- (2010) M M Günal et al. Journal of Simulation
- Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy
- (2009) Daniel Hollyman et al. JOURNAL OF IMMUNOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started